Preclinical Evaluation of the Assembly Modulator PAV-615 in a Mouse Model of <i>C9orf72</i>-Associated ALS/FTD.

PAV-615 treatment also led to a decrease in poly(GA) levels in 149R mice, although this reduction did not reach statistical significance ( Figure 3 D,G).

also in 111,027 other papers